309 related articles for article (PubMed ID: 2066784)
1. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeled monoclonal anti-carcinoembryonic antigen antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences.
Lind P; Langsteger W; Költringer P; Lechner P; Beham A; Arian Schad K; Eber O
Scand J Gastroenterol; 1989 Dec; 24(10):1205-11. PubMed ID: 2602902
[TBL] [Abstract][Full Text] [Related]
3. [99mTc anti-carcinoembryonic antigen in colorectal cancer].
Frederiksen PB; Rasmussen JW; Lassen E; Fenger C; Kronborg O; Ditzel H
Ugeskr Laeger; 1994 Mar; 156(11):1641-5. PubMed ID: 8009660
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
Yao YF; Yang Z; Li ZF; Gu J
World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
[TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
6. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
7. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy using 99mTc-labeled anti-CEA monoclonal antibody for patients with colorectal cancer.
Takenoshita S; Hashizume T; Asao T; Nakamura J; Katoh R; Oriuchi N; Ootake H; Inoue T; Watanabe N; Endo K
Anticancer Res; 1995; 15(2):471-5. PubMed ID: 7763024
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
10. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
12. [Tumor diagnosis by immunoscintigraphy with anti-CEA antibodies (Tc-99m MAK BW 431/26)].
Kroiss A; Tuchmann A; Schüller J; Weiss W; Wirth M; Auinger C; Neumayr A
Wien Klin Wochenschr; 1989 Sep; 101(18):621-6. PubMed ID: 2815778
[TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
[TBL] [Abstract][Full Text] [Related]
14. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
[TBL] [Abstract][Full Text] [Related]
16. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
[TBL] [Abstract][Full Text] [Related]
17. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
[TBL] [Abstract][Full Text] [Related]
18. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations].
Leitha T; Baur M; Steger G; Dudczak R
Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338
[TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody].
Rilinger N; Niemann H; Halbfass HJ
Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446
[No Abstract] [Full Text] [Related]
20. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26).
Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M
Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
